US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 29.550
  • +1.900+6.87%
Close Nov 6 16:00 ET
  • 29.550
  • 0.0000.00%
Post 16:21 ET
4.23BMarket Cap-10404P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 8.333M --
-- 2024/Q4 -- / 11.800M --
-- 2024/Q3 0.000 / 8.357M --
-- 2024/Q2 0.000 / 10.773M --
-- 2024/Q1 0.000 / 13.022M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 8.333M--
--2024/Q4-- / 11.800M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--

Unlock Free Earnings Estimates

Denali Therapeutics Earnings Reports

  • Denali Therapeutics | 10-Q: Quarterly report

    05:22

  • Denali Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1 18:57

  • Denali Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 10:18

  • Denali Therapeutics | 10-K: FY2023 Annual Report

    Feb 29 02:56

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data